Here's What Analysts Are Forecasting For Evonik Industries AG (ETR:EVK) After Its Second-Quarter Results
It's been a good week for Evonik Industries AG (ETR:EVK) shareholders, because the company has just released its latest quarterly results, and the shares gained 2.8% to €18.05. It was a credible result overall, with revenues of €3.9b and statutory earnings per share of €0.57 both in line with analyst estimates, showing that Evonik Industries is executing in line with expectations. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.
Taking into account the latest results, the current consensus from Evonik Industries' twelve analysts is for revenues of €14.6b in 2026. This would reflect a modest 3.7% increase on its revenue over the past 12 months. Per-share earnings are expected to jump 323% to €1.10. Before this earnings report, the analysts had been forecasting revenues of €14.5b and earnings per share (EPS) of €1.11 in 2026. The consensus analysts don't seem to have seen anything in these results that would have changed their view on the business, given there's been no major change to their estimates.
See our latest analysis for Evonik Industries
It will come as no surprise then, to learn that the consensus price target is largely unchanged at €18.05. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. The most optimistic Evonik Industries analyst has a price target of €21.00 per share, while the most pessimistic values it at €14.00. These price targets show that analysts do have some differing views on the business, but the estimates do not vary enough to suggest to us that some are betting on wild success or utter failure.
Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. One thing stands out from these estimates, which is that Evonik Industries is forecast to grow faster in the future than it has in the past, with revenues expected to display 7.5% annualised growth until the end of 2026. If achieved, this would be a much better result than the 2.4% annual decline over the past five years. Compare this against analyst estimates for the broader industry, which suggest that (in aggregate) industry revenues are expected to grow 3.5% annually. So it looks like Evonik Industries is expected to grow faster than its competitors, at least for a while.
The Bottom Line
The most obvious conclusion is that there's been no major change in the business' prospects in recent times, with the analysts holding their earnings forecasts steady, in line with previous estimates. Fortunately, they also reconfirmed their revenue numbers, suggesting that it's tracking in line with expectations. Additionally, our data suggests that revenue is expected to grow faster than the wider industry. The consensus price target held steady at €18.05, with the latest estimates not enough to have an impact on their price targets.
Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. We have estimates - from multiple Evonik Industries analysts - going out to 2028, and you can see them free on our platform here.
Before you take the next step you should know about the 4 warning signs for Evonik Industries that we have uncovered.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.